Tengfei Zhang

First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects

Shuyang Zhang, P. Hu, J. Zou, 2022, Frontiers in Pharmacology.